Hennion & Walsh Asset Management, Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$12.46 - $15.48 $83,494 - $103,731	-6,701 Reduced 16.49%	33,942 $431,000
Q2 2023 Aug 09, 2023	SELL	$13.28 - $15.96 $356,979 - $429,020	-26,881 Reduced 39.81%	40,643 $572,000
Q1 2023 Apr 20, 2023	SELL	$14.26 - $22.1 $26,823 - $41,570	-1,881 Reduced 2.71%	67,524 $1.04 Million
Q4 2022 Jan 12, 2023	SELL	$14.85 - $19.04 $447,400 - $573,637	-30,128 Reduced 30.27%	69,405 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $45,830 - $74,891	-3,702 Reduced 3.59%	99,533 $1.84 Million
Q2 2022 Jul 19, 2022	BUY	$9.11 - $13.98 $14,503 - $22,256	1,592 Added 1.57%	103,235 $1.36 Million
Q1 2022 Apr 26, 2022	BUY	$6.87 - $11.11 $89,413 - $144,596	13,015 Added 14.68%	101,643 $942,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $146,969 - $708,700	19,087 Added 27.45%	88,628 $866,000
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $184,267 - $258,712	6,964 Added 11.13%	69,541 $2.36 Million
Q2 2021 Aug 13, 2021	BUY	$32.73 - $47.95 $715,281 - $1.05 Million	21,854 Added 53.67%	62,577 $2.29 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $1.64 Million - $2.31 Million	40,723 New	40,723 $1.83 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.